Physician profile
John H Scott
NPI 1972982619
$2,892.46
in general payments reported to CMS, 2019-2025
7 companies · $200 in 2025
The $200 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,512 · 2022: $184 · 2023: $476 · 2024: $521 · 2025: $200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,197.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,197.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eli Lilly and Company | $1,411.61 | 2019 | |
| Jazz Pharmaceuticals INC. | $740.58 | 2022-2025 | Xywav |
| Inspire Medical Systems, INC. | $393.59 | 2023-2025 | Inspire |
| Harmony Biosciences LLC | $124.25 | 2022 | |
| Genentech USA, INC. | $99.99 | 2019 | |
| Itamar Medical INC | $87.32 | 2023-2025 | Watchpatone |
| Avadel Cns Pharmaceuticals, LLC | $35.12 | 2024 | Lumryz |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Scott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.